| 100 | 7 | 52 |
| 下载次数 | 被引频次 | 阅读次数 |
目的探讨艾地苯醌联合依达拉奉对急性脑出血患者炎性因子和氧化应激水平的影响。方法选择2018年1月至2020年1月收治的急性脑出血患者98例,依据随机数字表法分为观察组与对照组,每组49例。对照组给予依达拉奉30 mg+生理盐水100 mL,iv gtt,bid;观察组在对照组治疗基础上予艾地苯醌片30 mg,po,tid。2组疗程均为2周。比较2组临床疗效,以及治疗前后日常生活活动能力(ADL)评分、神经功能缺损程度(NIHSS)评分、炎性因子和氧化应激水平。结果治疗后,观察组总有效率高于对照组(93.88%vs 75.60%,P<0.05);观察组ADL评分高于对照组[(67.17±4.67)vs(54.28±5.19),P<0.05], NIHSS评分低于对照组[(8.12±1.43)vs(13.59±2.08),P<0.05);观察组血清IL-6、IL-8和TNF-α浓度分别为(38.93±4.26)、(30.54±3.27)和(65.21±14.05)ng·L-1,分别低于对照组的(49.63±5.64)、(41.32±4.56)和(84.35±12.24)ng·L-1(P<0.05);观察组血清MDA浓度低于对照组[(7.84±1.68)μmol·L-1vs(12.13±2.31)μmol·L-1,P<0.05],而SOD浓度高于对照组[(148.39±15.26)U·mL-1vs(115.62±18.39)U·mL-1,P<0.05)。结论艾地苯醌联合依达拉奉对急性脑出血患者疗效显著,可减轻炎性反应,改善氧化应激。
Abstract：AIM To investigate the effect of idebenone combined with edaravone on inflammatory factors and oxidative stress in patients with acute cerebral hemorrhage. METHODS A total of 98 patients with acute cerebral hemorrhage admitted to Ruian people's Hospital from January 2018 to January 2020 were randomly divided into observation group(49 patients) and control group(49 patients) respectively. The control group was given edaravone 30 mg+100 mL normal saline, iv gtt, bid, and the observation group was combined with idebenone 30 mg, po, tid, on the basis of the control group. The course of treatment in both groups was 2 weeks. The ability of daily life(ADL), NIH Stroke Scale(NIHSS), inflammatory factors and oxidative stress were compared before and after treatment. RESULTS The total effective rate of the observation group was higher than that of the control group(93.88% vs 75.60%, P<0.05). After treatment, ADL score of the observation group was higher than that of the control group [(67.17±4.67) vs(54.28±5.19), P<0.05], while the NIHSS score was lower than that of the control group [(8.12±1.43) vs(13.59±2.08), P<0.05]. After treatment, in the observation group levels of IL-6, IL-8 and TNF-α were(38.93±4.26),(30.54±3.27),(65.21±14.05) ng·L-1, respectively, which were lower than those of the control group(49.63±5.64),(41.32±4.56) and(84.35±12.24)ng·L-1(P<0.05). After treatment, serum MDA level of the observation group was lower than that of the control group [(7.84±1.68) μmol·L-1 vs(12.13±2.31) μmol·L-1, P<0.05], while the SOD level of the observation group was higher than that of the control group [(148.39±15.26) U·mL-1 vs(115.62±18.39) U·mL-1, P<0.05]. CONCLUSION The combination of idebenone and edaravone is effective in the treatment of acute cerebral hemorrhage.
[1] AHMED A,AHMED E,SOBHY E,et al.Haptoglobin genotyping and risk of cerebral vasospasm after aneurysmal subarachnoid hemorrhage[J].J Med Sci Res(Abingdon),2019,2(Suppl 3):224.
[2] 王翔,张铭,唐卫华.瓜蒌承气汤加减联合奥拉西坦治疗急性脑出血的临床研究[J].中西医结合心脑血管病杂志,2019,17(13):1947.
[3] ZHANG H,CHEN M,JIN G,et al.Experimental study on the detection of cerebral hemorrhage in rabbits based on broadband antenna technology[J].Comput Assist Surg(Abingdon),2019,24(Suppl 1):96.
[4] 刘超亮.依达拉奉注射液治疗急性脑出血的疗效分析[J].中国实用神经疾病杂志,2016,19(18):118.
[5] 阳军,欧阳娟,黄骥,等.单唾液酸四己糖神经节苷脂联合艾地苯醌治疗急性脑出血疗效及对患者神经功能影响[J].创伤与急危重病医学,2019,7(1):47.
[6] 中华医学会神经病学分会.中国急性缺血性脑卒中诊治指南2014[J].中华神经科杂志,2015,48(4):246.
[7] REVEL M,VIGUIER A,CAZZOLA V,et al.Acute ischaemic lesions are associated with cortical superficial siderosis in spontaneous intracerebral hemorrhage[J].Eur J Neurol(Abingdon),2019,26(Suppl 4):660.
[8] 赵金花,王益群,徐刚,等.急性脑出血患者细胞免疫功能及体液免疫功能的比较[J].中华实验外科杂志,2019,36(10):1895.
[9] 武玉秀,刘瑞东.阿戈美拉丁联合艾地苯醌治疗脑梗死后抑郁疗效及对生活质量影响[J].贵州医药,2019,43(10):1585.
[10] 夏东晖,张静,张新杰,等.艾地苯醌联合依达拉奉治疗急性脑梗死临床研究[J].中国药业,2019,28(23):66.
[11] 张景华.艾地苯醌联合20%甘露醇治疗急性脑出血临床疗效分析[J].淮海医药,2017,35(1):96.
[12] 许俊,潘景业.依达拉奉联合清热化瘀利水方治疗急性脑出血的效果观察[J].中国中医药科技,2018,25(1):85.
[13] 唐杰,姜学高,龚玉水,等.微创锥颅术联合依达拉奉治疗对急性脑出血患者氧化应激、脑血管功能及脑氧代谢的影响[J].海南医学院学报,2018,24(8):873.
[14] 刘志华,任翠萍,陈鹏,等.依达拉奉联合瑞舒伐他汀治疗急性脑出血临床效果研究[J].临床军医杂志,2018,46(12):1477.
[15] 高守君,李婧,吴艺,等.依达拉奉联合长春西汀注射液治疗急性脑出血的临床研究及对神经功能的影响[J].河北医学,2019,25(1):123.
[16] 李芳.老年急性脑出血患者血清炎症因子与病情严重程度的关系[J].心脑血管病防治,2017,17(3):195.
[17] 魏华,黄金秀,蔡海荣,等.急性脑出血患者中医证型与炎症因子的相关性研究[J].中医药信息,2018,35(4):91.
[18] 张小鹏.缺血性脑卒中患者血清HMGB1、sTLT-1含量与氧化应激反应、内皮损伤程度的相关性[J].海南医学院学报,2017,23(21):3021.
[19] 张巧莲,李双英,孙艳,等.氧化应激与缺血性脑卒中神经功能评分及神经功能恢复的相关性研究[J].现代医学,2019,47(3):287.
基本信息:
DOI：10.19577/j.1007-4406.2020.05.006
中图分类号:R743.34
引用信息:
[1]郑海军,戴楠楠,戴凯茜,等.艾地苯醌联合依达拉奉对急性脑出血患者炎性因子和氧化应激水平的影响[J].中国临床药学杂志,2020,29(05):342-346.DOI:10.19577/j.1007-4406.2020.05.006.
2020-09-25
2020-09-25